Trimethylene carbonate-caprolactone conduit with poly-p-dioxanone microfilaments to promote regeneration after spinal cord injury Acta Biomaterialia, https://doi.org/10.1016/j.actbio. 2017.11.028 Access to the published version may require subscription. N.B. When citing this work, cite the original published paper. containing poly-p-dioxanone microfilaments (PDO) with longitudinal grooves on regeneration after SCI in adult rats. In vitro studies demonstrated that different cell types including astrocytes, meningeal fibroblasts, Schwann cells and adult sensory dorsal root ganglia neurons can grow on the TC and PDO material. For in vivo experiments, the TC/PDO conduit was implanted into a small 2-3 mm long cavity in the C3-C4 cervical segments immediately after injury (acute SCI) or at 2-5 months after initial surgery (chronic SCI). At 8 weeks after implantation into acute SCI, numerous 5HT-positive descending raphaespinal axons and sensory CGRP-positive axons regenerated across the conduit and were often associated with PDO microfilaments and migrated host cells. Implantation into chronically injured SCI induced regeneration mainly of the sensory CGRP-positive axons. Although the conduit had no effect on the density of OX42-positive microglial cells when compared with SCI control, the activity of GFAP-positive astrocytes was reduced. The results suggest that a TC/PDO conduit can support axonal regeneration after acute and chronic SCI even without addition of exogenous glial or stem cells.
a b s t r a c t
Spinal cord injury (SCI) is often associated with scarring and cavity formation and therefore bridging strategies are essential to provide a physical substrate for axonal regeneration. In this study we investigated the effects of a biodegradable conduit made from trimethylene carbonate and e-caprolactone (TC) containing poly-p-dioxanone microfilaments (PDO) with longitudinal grooves on regeneration after SCI in adult rats. In vitro studies demonstrated that different cell types including astrocytes, meningeal fibroblasts, Schwann cells and adult sensory dorsal root ganglia neurons can grow on the TC and PDO material. For in vivo experiments, the TC/PDO conduit was implanted into a small 2-3 mm long cavity in the C3-C4 cervical segments immediately after injury (acute SCI) or at 2-5 months after initial surgery (chronic SCI). At 8 weeks after implantation into acute SCI, numerous 5HT-positive descending raphaespinal axons and sensory CGRP-positive axons regenerated across the conduit and were often associated with PDO microfilaments and migrated host cells. Implantation into chronically injured SCI induced regeneration mainly of the sensory CGRP-positive axons. Although the conduit had no effect on the density of OX42-positive microglial cells when compared with SCI control, the activity of GFAP-positive astrocytes was reduced. The results suggest that a TC/PDO conduit can support axonal regeneration after acute and chronic SCI even without addition of exogenous glial or stem cells.
Statement of Significance
Biosynthetic conduits can support regeneration after spinal cord injury but often require addition of cell therapy and neurotrophic factors. This study demonstrates that biodegradable conduits made from trimethylene carbonate and e-caprolactone with poly-p-dioxanone microfilaments alone can promote migration of different host cells and stimulate axonal regeneration after implantation into acute and chronic spinal cord injury. These results can be used to develop biosynthetic conduits for future clinical applications. Ó 2017 Acta Materialia Inc. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Traumatic spinal cord injury (SCI) affects several thousand people worldwide every year [1] and almost half of all injuries affect the cervical level spinal cord and result in complete loss of function below the level of injury. The injury is always associated with apoptotic cell death in the trauma zone, macrophage-mediated axonal dieback, activation of microglia and astrocytes, and production of growth-inhibitory molecules which effectively block axonal growth across the lesion site [2] [3] [4] [5] . When patients are discharged from hospital after 2-6 months they already have chronic SCI. In the chronic stage, the lesion epicentre becomes occupied by macrophages, meningeal fibroblasts and stromal cells forming a fibrotic scar surrounding cysts and cavities [6] .
Patients with SCI remain desperate for any treatment that could potentially reduce neuropathic pain, improve autonomic functions and restore limb movements [7] . In patients with chronic SCI, and in contrast to acute SCI, transplantation of bridging materials to reconnect divided spinal cord segments can be performed without interfering with spontaneous recovery. Recently it has been reported that transplantation of autologous peripheral nerve grafts in combination with olfactory ensheathing cells could have beneficial effects for human SCI [8] .
However, it is unlikely that it will always be possible to bridge significant tissue defects in human injuries using a limited number of autologous nerve grafts. Therefore biomimetic conduits could be required to provide a physical substrate for axonal growth. An ideal synthetic implant should support an optimal microenvironment for survival of various types of endogenous and transplanted cells, attenuate the inhibitory properties of the astrocytic scar and degenerating myelin, and stimulate axonal regeneration through the graft-spinal cord interface [9] [10] [11] [12] [13] [14] [15] . Moreover, it has been demonstrated that it may be sufficient to promote only short distance regeneration across the trauma zone into the spared spinal cord tissue beyond the lesion site to allow the formation of functional connections with, for example, propriospinal tract neurons [16, 17] .
Over the past years, a variety of different natural and synthetic biodegradable polymers have been tested in experimental SCI models to bridge the injury site, to deliver cultured glial and stem cells, growth factors and extracellular matrix molecules, and to stimulate axonal ingrowth [9] [10] [11] [12] [13] 15] . In addition, several nonbiodegradable acrylic polymers have been evaluated [9, 10, 13] . Although many of the reported biomaterials for experimental SCI have been found to be more efficient when they are combined with cells or neurotrophic factors [15, [18] [19] [20] [21] [22] [23] , recent studies have demonstrated that acellular conduits based on biodegradable polymers such as poly(e-caprolactone) (PCL) and poly(DL-lactideco-glycolide) (PLGA) can support regeneration in acute and chronically injured spinal cord [24, 25] and improve locomotion [24] . However, it has also been reported that PLGA conduits used in a rat model of SCI have relatively short degradation times and release carboxylic acids in buffer solution lowering the pH values [26] . To overcome the problem with early conduit degradation, a combination of PLGA with PCL has been tested in SCI experiments [25] .
In vitro studies have demonstrated that poly(trimethylene carbonate-co-e caprolactone) films induce more numerous neurite outgrowth from cultured cortical neurons than films made from poly(e-caprolactone) alone [27] . Bilayer patches prepared from the poly(trimethylene carbonate-co-e caprolactone) and loaded with ibuprofen have been found to reduce RhoA activation in the dorsal hemisection model of SCI [28] . When combined with matrigel TM and cultured Schwann cells, a tubular scaffold made from this polymer supports axonal growth after acute SCI [23] and peripheral nerve injury [29] .
To stimulate guided axonal regeneration after SCI, acellular conduits should promote migration, attachment and alignment of various host cells. It has been shown that microfilaments with longitudinal microgrooves made from PCL or poly-p-dioxanone (PDO) can provide pronounced Schwann cell alignment mimicking the growth-promoting bands of Büngner in the regenerating peripheral nerve [30] [31] [32] .
In the present study, we tested the hypothesis that biodegradable trimethylene carbonate-caprolactone block copolymer scaffolds containing poly-p-dioxanone guidance microfilaments with longitudinal microgrooves could support the migration of host cells and stimulate the regeneration of motor and sensory pathways after acute and chronic SCI in adult rats without addition of exogenous glial or stem cells.
Materials and methods

Preparation of scaffold and microfilaments
Tubular scaffolds and flat membranes were made from trimethylene carbonate (Boehringer Ingelheim), e-caprolactone (Fluka, Germany), glycolide (ITV Denkendorf Productservice Ltd., Germany), N-methyl-2-pyrrolidon (NMP) as a solvent (Sigma, Germany) and polyethylene glycol (PEG; 2 kD; Sigma). Two ABABlock-copolymers from trimethylene carbonate, e-caprolactone with 12% glycolide (TCG; Table 1 ) and without glycolide (TC; Table 1 ) were synthesised using a two-step ring-opening polymerisation. In a conical 5 L reactor a prepolymer was prepared from ecaprolactone and trimethylenecarbonate with diethylene glycol as initiator and tin octoate as catalyst at 210°C. After reaction of the prepolymer was completed, the temperature was decreased to 145°C and e-caprolacone was added to the melt to synthesize the e-caprolactone-trimethylene-block-co-polymer. The details are described in the patent EP2096130 B1 [33] . Adjustment of the degradation profile and mechanical properties was carried out by varying percentages of trimethylencarbonate and ecaprolactone with glycolide. Tubular scaffolds (Fig. 1A) were fabricated using wet phase inversion technique and have an inner and an outer ''skin" layer. Microfilaments with longitudinal grooves (Fig. 1B) were made from poly-p-dioxanone (BMG, Japan) by using a special extrusion technique with star-shaped nozzles producing a yarn with 44 microfilaments. For transplantation studies, tubular scaffolds were filled with PDO microfilaments.
Polymer properties
Inherent viscosity (i.V.) of polymers was measured in hexafluoroisopropanol (c = 0.8 g/dl, T = 30°C, Oa). Melting point (Tm), heat of fusion (Hf) and glass transition point (Tg) were determined during thermal analysis using Mettler Toledo DSC 1 in combination with the Stare-Software (Mettler-Toledo Inc, USA). Maximum tension and elongation at maximum force were measured using a Zwick BZ1-MM14450.ZW01 (Zwick GmbH & Co. KG, Germany). Tensile strength of the PDO yarn was measured using an Uster Tensorapid 3 (Uster Technologies AG, Switzerland). Pore distribution, diameter and wall thickness were investigated by scanning electron microscopy. Degradation profiles of the polymers were studied in phosphate buffered solution at pH 7.4 and 37°C according to DIN EN ISO 10993-13. Six tubular scaffolds per degradation time point, either non-sterile or c-sterile, about 10 cm in length, were incubated in 50 ml of phosphate buffered solution at pH 7.4 in a water bath at 37°C. After defined time points (4 and 12 weeks) the tubular scaffolds were removed from the buffered solution, excessive buffer was drained away and maximum tension and elongation at break measured in wet state. Non-sterile PDO microfilaments were incubated in the same way for 2 and 4 weeks and linear tensile strength was measured.
Experimental animals
The experiments were performed on adult (12-14 weeks old, n = 30) and 5-day-old (n = 6) female Sprague-Dawley rats (Taconic Europe A/S, Denmark). The animal care and experimental proce- 
Culture of cortical astrocytes
Primary cultures of astrocytes were prepared from cerebral cortices obtained from 5-day-old rats as described previously [34] . After enzymatic digestion and trituration, the cells were resuspended in growth medium (Dulbecco's Modified Eagle Medium (DMEM), 10% (v/v) FCS and 1% (v/v) penicillin/streptomycin) and plated onto a 25 cm 2 poly-l-lysine-coated (PLL) tissue culture flask.
When cells reached confluence after 8 days, the flasks were shaken at 150 rpm for 4 h to detach the microglia. The cells were cultured Fig. 1 . Scanning electron microscopy of the trimethylencarbonate-caprolactone tubular conduit, TC (A) and poly-p-dioxanone microfilaments with longitudinal grooves, PDO (B). Note the porous structure of the wall of the TC conduit. Graphs in (C-E) demonstrate changes in polymer mechanical properties during degradation tests. TCG is a polymer based on trimethylene carbonate, e-caprolactone and glycolide. Error bars show SD. P < .01 for time-course of material degradation with exception for maximum tension for non-sterile TC at 0 days and 12 weeks and elongation at maximum force for non-sterile TC and TCG at 0 days and 4 weeks (P > .05). P < .001 between non-sterile TC, TCG, gamma-sterilized TC, TCG at different time points with exception for elongation at maximum force for non-sterile TC and TCG at 0 days and 4 weeks (P > .05). Scale bar 500 mm (A) and 100 mm (B).
for an additional 14 days. The resulting culture contained 95% GFAP-positive astrocytes and 5% OX42-positive microglial cells.
Culture of meningeal fibroblasts
Primary cultures of meningeal fibroblasts were prepared from brain meninges obtained from 5-day-old rats (n = 6) as described previously [35] with minor modifications. In brief, meninges were cut into small pieces and transferred into a 25 cm 2 PLL-coated tissue culture flask with minimal volume of DMEM with 10% (v/v) FCS to allow pieces to attach to the flask surface. Cultures were incubated at 37°C and 5% CO 2 for 2 weeks. When cells reached confluence the flasks were shaken at 150 rpm for 4 h to detach the weakly adherent microglia and macrophages. The remaining cells were cultured for an additional 14 days. The purity of meningeal fibroblasts was assessed using immunostaining for Thy1.1, fibronectin, vimentin, OX42 and GFAP. The resulting culture contained 95% Thy1.1/fibronectin positive meningeal fibroblasts.
Schwann cell culture
Primary cultures of Schwann cells were prepared from the sciatic nerves of adult rats (n = 2) as described previously [22] . In brief, sciatic nerves were dissected into DMEM with 10% (v/v) FCS, cut into small pieces and incubated at 37°C and 5% CO 2 for 2 weeks. After enzyme digestion and trituration the cells were plated onto 25 cm 2 poly-D-lysine-coated (PDL) tissue culture flasks with Schwann cell growth medium, supplemented with 10 lM forskolin (Sigma Aldrich) and neuregulin NRG1 (R&D Systems). The purity of Schwann cells was assessed using immunostaining for low affinity nerve growth factor receptor p75 and S-100 protein and was approximately 95%.
Cell proliferation assay
AlamarBlue TM assay (Serotec) was used to evaluate the effects of biomaterials on cell proliferation [36] . The flat sheets of TC material were cut to fit the wells of the 24-well culture plate and incubated with DMEM for 24 h at 37°C. The PDO microfilaments were cut into 6 mm long pieces and 5 mg of the material was transferred into polyethylene terephthalate membrane cell culture inserts (Costar; 3.5 mm pore size), placed into 24-well culture plate and incubated with DMEM for 24 h at 37°C. Astrocytes and fibroblasts (the main cell types forming astrocyte and fibrotic scars after spinal cord injury) were resuspended and seeded at a density of 5000 cells/well. Three independent co-culture experiments with six repetitions were carried out for each cell type. The cells were seeded on (i) PLL-coated culture plate alone, (ii) PLL-coated culture plate with cell culture inserts alone, (iii) PLL-coated culture plate with cell culture inserts containing PDO microfilaments and (iv) uncoated culture plate with TC material. The cultures were maintained under identical conditions. The optical density of AlamarBlue was obtained by measuring changes of absorbance at 570 nm and using a background correction at 600 nm. The growth medium in the wells and cell culture inserts was replaced at the same time on day 1, 3 and 5 by fresh medium (250 ml) containing 10% AlamarBlue. Exactly 12 h later, 100 ml of the AlamarBluecontaining medium was transferred into 96-well culture plates and the optical density was measured using a microplate reader (Spectra Max 190, Molecular Device, USA).
Neurite outgrowth assay
The assay was based on neurite outgrowth of sensory neurons from adult rat dorsal root ganglia (DRG) on PDO microfilaments. The PDO microfilaments (6mm long, weight 0.5 mg) were incubated for 24 h at 37°C in DMEM or in DMEM with laminin (20 mg/ml; Sigma-Aldrich), briefly washed in fresh DMEM and transferred into Lab-Tek Ò 8-chambers slides. Schwann cells and meningeal fibroblasts were seeded on PDO microfilaments at concentrations of 25 Â 10 3 cells/well. Cells were allowed to attach for 6 h and non-adherent cells were washed out with fresh DMEM. Cultures of DRG neurons were prepared from adult rats (n = 3) as described previously [34] and 5000 neurons were added to the Lab-Tek slides containing (i) plain PDO microfilaments, (ii) laminin-coated PDO microfilaments, (iii) PDO microfilaments with meningeal fibroblasts, (iv) PDO microfilaments with Schwann cells, (v) laminin-coated PDO filaments with meningeal fibroblasts and (vi) laminin-coated PDO filaments with Schwann cells. Three repetitions were carried out for each experimental group. The DRG neurons were cultured in Neurobasal TM -A medium with B-27 supplement (Invitrogen Life Technologies, Sweden) and 0.5 mM L-glutamine (Sigma Aldrich, Sweden AB). Cultures were analysed after 48 h. The images of bIII tubulin-positive DRG neurons on PDO filaments (see Section 2.12 below) were captured using Nikon DS-U2 digital camera, the neurites were traced using Image-Pro Plus software (Media Cybernetics, Inc., USA) and the mean longest neurite length was determined.
RT-PCR
Total RNA was isolated from the cell pellets of astrocytes or meningeal fibroblasts cultured with biomaterials (see Cell proliferation assay) for 14 days using an RNeasy TM kit (Qiagen, Sweden). The One-Step RT-PCR kit (QIAGEN Ltd.) was used for all RT-PCR as per the manufacturer's instructions with the addition of 1 ng total cellular RNA. A thermocycler (Biometra, Germany) was used with the following parameters: a reverse transcription (RT) step (50°C, 30 min) and a nucleic acid denaturation/RT inactivation step (95°C, 15 min) followed by 32-35 cycles of denaturation (95°C, 30 s), annealing (30 s) and primer extension (72°C, 1 min) followed by a final extension incubation (72°C, 5 min). Forward and reverse primer (all 5 0 ? 3 0 ) pairs (SigmaAldrich) with annealing temperatures used are listed in Table 2 . Amplicons were electrophoresed (50 V, 90 min) through a 1.5% (w/v) agarose gel and the size of the PCR products estimated using Hyperladder IV 
Spinal cord injury and conduit implantation
After cervical laminectomy, the dura mater was cut longitudinally to expose the dorsolateral surface of the C3-C4 cervical spinal cord segments. The entry zones of the left C3 and C4 dorsal roots were identified and the spinal cord was vertically penetrated with a 23 gauge needle. One blade of a pair of microscissors was inserted into the stab wound and the cord was hemisected from the lateral side using the other blade of the scissors. For implantation of the TC/PDO conduit into acute spinal cord injury (SCI), the tissue between the two hemisection sites was carefully removed to create a 2-3 mm long hemicavity. After haemostasis, TC/PDO conduit was trimmed to fit the lesion site and implanted into the cavity (n = 7 rats, one conduit per animal). The injury to the lateral funiculus interrupts descending motor tracts from the brainstem and ascending sensory and propriospinal pathways. The corticospinal tract in the dorsal column was spared. After injury, the animals typically displayed signs of paralysis in the upper limb on the side of injury. The conduit and the adjacent dura mater were covered with a thin layer of Spongostan Ò (Johnson & Johnson Medicals, UK) soaked in normal saline and the muscles and skin were closed in layers. For implantation into chronic SCI, spinal cord was first hemisected at C3 cervical level (as described above). At 2 months (n = 5) or 5 months (n = 3) after initial surgery, the injury site was exposed, the scar tissue was resected, a 2-3 mm long cavity was created and the conduits were transplanted into the cavity. The rats were sacrificed 8 weeks after conduit implantation. Rats with C3 cervical spinal cord hemisection alone and normal rats (n = 5) served as baseline controls. After surgery, the rats were given the analgesic, Finadyne (Schering-Plough, Denmark; 2.5 mg/kg, s.c.), normal saline (5 ml, s.c.) and benzylpenicillin (Boehringer Ingelheim; 30 mg). Each animal was housed alone in a cage with free access to food and water and exposed to 12-h light/dark cycles.
Tissue processing
At the end of experiment, the animals were deeply anaesthetized with an intraperitoneal overdose of sodium pentobarbital and transcardially perfused with Tyrode's solution followed by 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer (pH 7.4). Spinal cord segments C3-C5 were removed and transferred into the same fixative for 2-3 h. The tissue blocks were cryoprotected in 10% and 20% sucrose for 2-3 days and frozen in liquid isopentane. Serial horizontal 16-mm-thick sections were cut on a cryomicrotome (Leica Instruments), thaw-mounted in pairs onto SuperFrost Ò Plus slides, dried overnight at room temperature and stored at À85°C before processing.
Immunostaining
Immunostaining was performed on cultured cells and spinal cord sections. After blocking with normal serum, the following primary antibodies were used: mouse anti-fibronectin (1:500; Millipore), mouse anti-vimentin (1:1000; Chemicon), mouse antiThy1.1 (CD90; (1:1000; Chemicon), mouse anti-low-affinity NGF p75 receptor (1:500; Abcam), mouse anti-bIII tubulin (1:200; Sigma Aldrich), rabbit anti-bIII tubulin (1:200, Abcam), rabbit anti-glial fibrillary acidic protein, GFAP (1:1000; Dako), rabbit anti-serotonin, (5HT; 1:1000; Dako), rabbit anti-calcitonin generelated peptide, (CGRP; 1:1000; Chemicon), a cocktail of monoclonal antibodies reacting with 68 kDa, 160 kDa and 200 kDa neurofilament proteins (panNF in Graphical Abstract; 1:200; Zymed; Labora AB), rabbit anti-S-100 protein (1:1000; Dako) and monoclonal antibodies reacting with C3bi complement receptors (OX42; 1:250, Serotec). All primary antibodies were applied for 2 h at room temperature. After rinsing in PBS, secondary goat anti-mouse and goat anti-rabbit antibodies Alexa Fluor Ò 488 and Alexa Fluor Ò 568 (1:300; Molecular Probes, Invitrogen) were applied for 1 h at room temperature in the dark. The slides were coverslipped with ProLong mounting media containing 4 0 -6-diamido-2-phenylindole (DAPI; Invitrogen Life Technologies, Sweden). The staining specificity was tested by omission of primary antibodies.
Quantification of axonal regeneration and glial reaction
Regeneration of CGRP-positive axons and 5HT-positive axons in the conduit was measured using a Nikon Eclipse 90i microscope equipped with an optical microgrid at Â600 final magnification. Axon profiles were counted in a line perpendicular to the direction of the conduit at 500 mm from the rostral and caudal conduit-spinal cord interfaces and in the middle of the conduit, and the total number of axon profiles per section was determined. GFAP-positive astrocytes and OX42-positive microglial cells were studied in 20 randomly selected horizontal sections from the C3-C5 spinal cord segments at the level of lamina VII in normal rats, at 8 weeks after spinal cord injury and after injury followed by TC/PDO conduit implantation. The sections were captured at Â400 final magnifications with a Nikon DS-U2 digital camera in C3 spinal segments 500 mm rostral to the injury border. The images were taken with minimal background and the resolution was 1280 Â 1024 pixels for all studied sections. Using pre-recorded macros in Adobe Photoshop CS6 software, 150 Â 150 mm areas (3.8 pixels per 1 mm tissue length) were randomly selected. The images of the selected areas were then transferred to Image-Pro Plus software (Media Cybernetics, Inc., USA) to quantify the density of immunostained profiles.
Statistical analysis
One-way analysis of variance (ANOVA) followed by a post hoc Newman-Keuls Multiple Comparison Test was used to determine statistical differences between the experimental groups (Prism Ò , GraphPad Software, Inc; San Diego, CA).
Results
Characterization of biomaterials
The chemical properties of the synthesised block-copolymers are shown in Table 1 . Both trimethylene carbonate/e-caprolactone (TC) and trimethylene carbonate/e-caprolactone/glycolide (TCG) polymers have an ABA-structure, where the hard-blocks A consist only of e-caprolactone. Block B is the soft segment portion (SSP), which is a completely amorphous pre-polymer, derived from a monomer mixture of e-caprolactone (CL) and trimethylene carbonate (TMC) and in the case of TCG -glycolide (G).
The tubular scaffold, formed by phase inversion technique, had an inner diameter of 1100 mm, a wall thickness of 200-300 mm and showed an inner and an outer skin layer with micro porous structure and in-between a finger-like structure of big pores (Fig. 1A) . The PDO yarn (Fig. 1B) had a titre of about 7 tex (linear mass density of fibres, g/1000 m), a tenacity of 30-32 cN/tex and an elongation at break of 35-40%. Inherent viscosity was 1.4 dl/g and monomer content 1.5 wt-%. Heat of fusion of the orientated yarn was 70 J/g. Yarn samples for biological tests were washed in acetone to remove spin finish.
Degradation of the TC and TCG tubular scaffolds showed a decrease in inherent viscosity from 1.9 to 1.26 dl/g and from 2.0 to 0.9 dl/g at 12 weeks, respectively. Sterilization of the TC and TCG scaffolds with gamma radiation led to a decrease in inherent viscosity within 12 weeks from 1.5 to 0.9 dl/g and from 1.4 to 0.4 dl/g. TC scaffolds did not show any significant changes in maximum tension after 12 weeks in phosphate buffered solution ( Fig. 1C ; P > .05) but elongation at maximum force was decreased to 69% ( Fig. 1D ; P < .01). In contrast, maximum tension of TCG scaffolds was reduced to 24% after 12 weeks in phosphate buffer ( Fig. 1C ; P < .01) and elongation at maximum force was decreased to 5% ( Fig. 1D ; P < .01). Gamma-sterilization led to a further decrease in maximum tension and elongation at maximum force for both TC and TCG scaffolds (Fig. 1C, D ; P < .001). Degradation experiments with non-sterile PDO-filament yarns demonstrated that linear tensile strength was decreased to 54% after 2 weeks and to 27% after 4 weeks in buffer solution ( Fig. 1E ; P < .001). Based on these results we subsequently used the TC scaffold for both in vitro and in vivo studies.
Effects of TC scaffold and PDO microfilaments on astrocytes and fibroblasts
Transcript levels of astrocytic marker glial fibrillary acidic protein (GFAP), various growth inhibitory chondroitin sulphate proteoglycans (CSPG) produced by reactive astrocytes (neurocan, phosphacan and versican), matrix molecule tenascin C, proinflammatory cytokine TGF-b and adhesion molecule b1 integrin were studied in cultures of cortical astrocytes and meningeal fibroblasts using RT-PCR ( Fig. 2A, B) . The results demonstrated that TC scaffold and PDO microfilaments had no significant effect on the expression of GFAP, neurocan, tenascin C and TGF-b in cultured astrocytes but markedly increased transcript levels of phosphacan and versican ( Fig. 2A) . With respect to the meningeal fibroblasts, the biomaterials increased expression of tenascin C, TGF-b and b1 integrin (Fig. 2B ).
An AlamarBlue TM cell assay showed that the proliferation rate of cultured astrocytes and meningeal fibroblasts increased over a 5 days period in PLL-coated culture plates and in PLL-coated culture plates with cell culture inserts containing PDO microfilaments (Fig. 2C, D ). There were no significant differences between the cell culture inserts alone and inserts containing PDO filaments (Fig. 2C, D) . However, both astrocytes and fibroblasts demonstrated lower proliferation rates on culture plates with TC membranes (P > .05 for astrocytes on 3 days versus 5 days and fibroblasts on 1 days versus 3 days).
Cell attachment and DRG neurite outgrowth on PDO microfilaments
Cell bodies of sensory DRG neurons attached to the uncoated PDO microfilaments but did not project any neurites after 48 h in culture (Fig. 3A) . Coating of the PDO material with laminin increased the number of attached DRG neurons and induced outgrowth of numerous long neurites ( Fig. 3B  and G) . To test if PDO microfilaments could potentially support the migration and attachment of host cells following SCI, we seeded meningeal fibroblasts and cultured Schwann cells on the material and found that laminin-coated PDO microfilaments supported attachment and alignment of the cells (Fig. 3C, D) . Addition of sensory DRG neurons to the uncoated PDO microfilaments seeded with fibroblasts or Schwann cells induced neurite outgrowth (Fig. 3G ) which was further enhanced by coating PDO filaments with laminin (P < .05; Fig. 3E, F, G) .
Implantation of TC/PDO conduits into injured spinal cord
At 8 weeks after implantation, the TC/PDO conduit was well integrated into both acutely and chronically injured spinal cord, forming continuous bridges across the lesion site.
Numerous host cells migrated into the TC/PDO conduit after acute and chronic SCI. Astrocytes usually were found within the 500-600 lm wide area on both ends of the implant with single cells migrating for 800-1000 lm into the conduit after acute SCI (Fig. 4A) . ED1-positive macrophages (Fig. 4B ) and OX42-positive macrophages (Fig. 5A, C; Fig. 6B ) were often found in close association with PDO microfilaments. Spindle shaped Schwann cells from the injured C3-C4 dorsal and ventral roots also moved into the conduit and extended their processes along PDO microfilaments (Fig. 4C) .
Immunostaining for calcitonin gene-related peptide (CGRP) revealed regenerating sensory axons throughout the conduit after implantation into acute SCI and chronic SCI (Fig. 5 and Fig. 6 ). After conduit implantation into acute SCI, 52.6 ± 3.0 (mean ± S.E.M.) axon profiles per section were found in the conduit (Fig. 5E ). The number of CGRP-positive axon profiles was decreased after conduit implantation into 2 months chronic SCI (34.3 ± 3.3; P < .01; Fig. 5E ) and 5 months chronic SCI (18.2 ± 1.8; P < .01; Fig. 5E ), respectively. However, regenerating axons were observed in all studied areas of the conduit. In contrast, no regeneration of CGRP-positive axons into the trauma zone was found in control untreated SCI group (Fig. 5D) . In addition, a small bundle of fibers was found outside the conduit along the connective tissue sheets surrounding TC scaffold (Fig. 5A) . CGRP-positive axons often displayed rostro-caudally oriented growth along the PDO microfilaments surrounded by p75-positive Schwann cells (Fig. 4E ) and OX42-positive macrophages (Fig. 5C) .
Importantly, implantation of the TC/PDO conduit into the acute SCI also promoted ingrowth of descending serotoninergic 5HT-positive raphaespinal axons from the brainstem. Regenerating axons entered the conduit from the cranial end ( Fig. 7A and 7A-i) , extended across the conduit along the PDO microfilaments ( Fig. 7A and 7A -ii-iv) and host Schwann cells (Fig. 4D) , and reached the distal conduit-spinal cord interface but did not enter the caudal spinal cord (Fig. 7A-v) . Quantitative analysis revealed 20.9 ± 3.2 axon profiles per section in the conduit. However, there was no regeneration of 5HT-positive axons after conduit implantations into 2 months and 5 months chronic SCI (Fig. 7B ) and in control untreated SCI animals (Fig. 7C) . In some animals, single terminals were found within the short 100-150 mm distance from the rostral end of the conduit.
To evaluate the effects of TC/PDO conduit on astroglial and microglial cell reactivity in the acute SCI model, we analysed the GFAP-positive astrocytes and OX42-positive microglial cells in C3 cervical spinal cord segments. SCI alone induced significant two to threefold increases in GFAP-and OX42-immunoreactivity (P < .001; Fig. 8) . Implantation of the conduit reduced the density of reactive astrocytes (P < .05) but had no effects on activation of microglia.
Discussion
This study shows that Schwann cells and fibroblasts easily attach to the PDO microfilaments and support in vitro neurite outgrowth from adult sensory DRG neurons. After in vivo implantation, TC/PDO conduits promote migration of different cell types including Schwann cells, and promote regeneration of sensory axons in the acutely and chronically injured spinal cord. Furthermore, the TC/PDO conduit induces significant ingrowth of descending motor raphaespinal axons from the brainstem after acute SCI and attenuates the astrocyte reaction rostral to the injury site. However, the conduit does not affect microglial cell reactivity in spinal cord tissue.
Properties of the ABA-block copolymers
ABA-block copolymers consisting of hard segments from pure e-caprolactone and amorphous soft segments made from mixtures of e-caprolactone, trimethylene carbonate, and in part with relatively low glycolide content, show very low glass transition points around À50°C and therefore have a high pliability level and low bending stiffness. Polymers based on e-caprolactone and trimethylene carbonate have reduced acid equivalents per weight unit compared to glycolide and lactide based polymers and their degradation products have higher pk-values (lower acidity). This results in a significantly reduced acidification of the surrounding tissue during degradation and reduces irritation and scar formation which could affect axonal regeneration [15, 37] .
Changing the glycolide content in the ABA-block copolymers allows for adjustment of the degradation profile which could be important for bridging the gaps of different length. However, hydrolytic degradation will still lead to small amounts of free glycolic acid. Our study demonstrated that both maximum tension and elongation at maximum force for non-sterile TCG scaffolds were significantly reduced after 12 weeks to 24% and 5%, respectively. Since functional regeneration after SCI could take months or even years, these rapid degradation profiles were not optimal for potential clinical applications.
We tested whether sterilization of the TC and TCG scaffolds with gamma-irradiation affects their brittleness, probably as a result of scission of tie-chains of the polymer in the amorphous regions. We found that gamma-sterilized TC and TCG scaffolds had significantly reduced strength when compared to non-sterile materials. These results suggest that other methods of sterilization for clinical applications (e.g. by ethylene oxide) should be evaluated.
Relatively rapid, within 4 weeks degradation of the PDO microfilaments could potentially hamper their clinical application for the long nerve gaps often seen following injuries to the brachial plexus and large peripheral nerves. However, our findings demonstrated Fig. 2 . RT-PCR analysis of astrocytes (A) and meningeal fibroblasts (B) growing on culture plastic (PLST), TC scaffold (TC) or PDO microfilaments (PDO) for expression of glial fibrillary acidic protein (GFAP), proteoglycans neurocan, phosphacan and versican, the extracellular matrix molecule tenascin C, transforming growth factor beta (TGF-b) and transmembrane receptor b1 integrin. 18S is used as a housekeeping gene. Histograms show proliferation of astrocytes (C) and meningeal fibroblasts (D) on culture plastic (PLST), on culture plastic with insertion alone (INS) and with PDO microfilaments (INS + PDO), and on TC scaffold. Error bars show S.E.M. P < .01 is indicated by ** and P < .001 is indicated by ***.
that in short 2-3 mm long gaps in spinal cord, PDO microfilaments supported both the migration of various host cells, including Schwann cells, and guided axonal regeneration of sensory and descending motor fibers across the length of the conduit.
Although we did not study the toxicity and immunogenicity of the TC/PDO in our spinal cord injury model, both the TC and PDO polymers are used to manufacture surgical synthetic absorbable monofilament sutures. For example, PDO is used in the PDS Ò II suture (Ethicon Inc.) and MonoPlus Ò (B. Braun Melsungen AG).
The TC is used in Monosyn Ò (B. Braun Melsungen AG) and Caprosyn TM (Covidien AG; Medtronic Minimally Invasive Therapies).
Interaction of biomaterials with cultured cells
Our results showed that TC scaffolds do not stimulate significant proliferation of astrocytes and meningeal fibroblasts which is an important requirement for biomaterials intended for implantation into injured spinal cord with the reactive astrocytic and fibrotic scars.
Disruption of the spinal cord meninges following injury is a known factor eliciting host tissue reaction characterized by the migration of the meningeal fibroblasts and astrocytes toward the injury site and upregulation of extracellular matrix molecules expression [6, 38, 39] . Matrix deposition and glial and meningeal cell colonization of the host-graft interface can compromise the performance of many types of implantable spinal cord devices. Our in vitro studies suggested that both of the tested materials, TC scaffold and PDO microfilaments, are biocompatible with astrocytes and do not increase expression of GFAP and neurocan, a known growth inhibitory member of the CSPGs. The transcript levels of two other tested proteoglycans, the phosphacan and versican, were elevated which could contribute to the failure of regenerating axons to re-enter spinal cord. However, our preliminary results (Novikova, unpublished observations) did not show significant differences in transcript levels for neurocan, phosphacan and versican after SCI alone and following conduit implantation. Another extracellular matrix molecule, tenascin C, was mainly elevated in the meningeal fibroblasts. Tenascin C is a secreted extracellular matrix glycoprotein which is transiently expressed by neural and non-neural cells during development and plays a role in the extracellular matrix remodelling during tissue repair [40] . Tenascin C is considered both as a repulsive substrate for neuronal and astrocytic growth [41, 42] and as a permissive one, by providing axonal guidance cues [43] . Tenascin C production in astrocytes can be modulated by inflammatory cytokines and growth factors. For example, Smith and colleagues have demonstrated that the synergic action of TGF-b1 and basic fibroblast growth factor stimulates the expression of tenascin C [44] . Therefore the upregulation of tenascin C could be related to the increased level of transcript for TGF-b1 in meningeal fibroblasts.
Another interesting observation was that both TC scaffold and PDO microfilaments upregulated transcript level of b1 Integrin in the meningeal fibroblasts. Integrins act as receptors for extracellular matrix proteins and b1 integrin is the major fibronectin receptor on most cells. This integrin mediates such cellular responses to fibronectin substrates as adhesion, migration, assembly of extracellular matrix and signal transduction [45] , and as such is likely to play multiple roles in response to neural damage. Axons, that will regenerate in the injured spinal cord express b1 integrins [46] . Also, b1-integrin is likely to be required specifically in astrocytes for their normal maturation in the uninjured brain and the down regulation of integrin after injury may be required for astrocyte activation [47] . For example, it has been shown that tenascin C acts through b1 and a9 integrin-dependent cell adhesion in astrocytes [42, 48] . The overexpression of b1 integrin by meningeal fibroblasts cultured on TC material or in the presence of PDO filaments may be related to the increased production of fibronectin and tenascin C.
Our in vitro results also demonstrated that neurite outgrowth from sensory DRG neurons was significantly improved when PDO microfilaments were seeded with meningeal fibroblasts or adult rat Schwann cells. This observation is important because our in vivo implantation data showed that regenerating axons often followed PDO microfilaments and migrating host cells. These findings are in line with previous observations that Schwann cells and meningeal fibroblasts migrate to the site of spinal cord injury, colonize the host-graft interface and express a number of extracellular matrix molecules including fibronectin, laminin, collagen, and CSPGs [49] [50] [51] .
TC/PDO conduit promotes axonal regeneration
In our previous investigations we have tested biodegradable implants based on poly-b-hydroxybutyrate (PHB) fibres in an acute SCI model [22, 52] . When supplemented with cultured Schwann cells, such implants provide neuroprotection to injured supraspinal neurons. However, transplantation of PHB into SCI also induced extensive astrocytic and microglial cell reactions and this prompted us to search for alternative biomimetic materials. Regeneration of CGRP and 5HT axons into the PHB conduits only happens when the conduit was supplemented with cultured Schwann cells. Nevertheless, in contrast to the present study, we never found 5HT axons growing across the conduit.
A tubular conduit based on e-caprolactone and trimethylene carbonate block copolymer without PDO filaments has been previously tested for peripheral nerve injury [29] and acute SCI in adult rats [23] . The conduit was prepared by dipping a glass rod into the polymer solution and then precipitating it in demineralized water. A wall thickness of about 100 mm was reported. When the conduit was supplemented with Matrigel TM , a laminin rich soluble basal membrane extract of the Engelbreth-Holm-Swarm tumour cell line, no regenerating neurofilament-positive axons were found in the middle portion of the conduit after transplantation into injured spinal cord. However, axon regeneration into the conduit was induced after addition of cultured allogeneic neonatal Schwann cells [23] .
In our study, the conduit was fabricated using wet phase inversion technique and had a wall thickness of about 200-300 mm. We did not find any signs of conduit fragmentation after 8 weeks survival. Moreover, even without addition of any cultured glial cells, we observed regeneration of nerve fibers across the entire length of the conduit. The possible explanations for these differences could be the presence of PDO microfilaments in our conduits and a massive invasion of the host cells including Schwann cells, macrophages and astrocytes. All these cell types are well known to produce various extracellular matrix molecules which could be more optimal for axonal regeneration than growth factors in Matrigel TM matrix. Previous studies with transplantation of different biomaterials containing Matrigel TM matrix alone into injured spinal cord also reported very limited axonal regeneration [18] .
In the experimental adult rat SCI model, chronic injury is defined as ''one that is at least 4 weeks old since before this time both structural and functional measures are changing actively" [53, 54] . In our study, we transplanted TC/PDO conduits into 2 months and 5 months old chronic SCI and found the same general 
Conclusions
The results of this study show that a TC scaffold with PDO guiding microfilaments can bridge both acute and chronic SCI and promote axonal regeneration across the implant. However, additional treatment strategies to increase regenerative response from the chronically injured central neurones and to modify the host-graft interface allowing regenerating axons to reach the spinal cord tissue beyond the conduit should be considered. This work was supported by the ERA-Net European transnational collaborative project: ''Nano-Functionalised Implants for the Regenerative Treatment of Spinal Cord and Nerve Lesions" (Nano4Neuro), the Swedish Research Council (grant 2014-2306, Medicine and Health), Umeå University (insamlingsstiftelsen för medicinsk forskning) and through a regional agreement between Umeå University and Västerbotten County Council (ALF).
